• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

德国 S3 指南前列腺癌：放射肿瘤学家的观点。

The German S3 guideline prostate cancer: aspects for the radiation oncologist.

机构信息

Department of Radiotherapy and Radiooncology, University Medicine Mannheim, University of Heidelberg, Heidelberg, Germany.

出版信息

Strahlenther Onkol. 2010 Oct;186(10):531-4. doi: 10.1007/s00066-010-2193-3. Epub 2010 Sep 30.

DOI:10.1007/s00066-010-2193-3
PMID:20890742
Abstract

This report summarizes the relevant aspects of the S3 guideline prostate cancer for the radiation oncologist. Treatment decision and dose prescription are discussed, as well as technical performance of external beam radiotherapy and brachytherapy. The relevant literature is cited to allow an overview of the current recommendations.

摘要

本报告总结了 S3 指南中与放射肿瘤学家相关的前列腺癌内容。讨论了治疗决策和剂量处方，以及外照射放疗和近距离放疗的技术性能。引用了相关文献，以便对当前建议进行概述。

相似文献

1
The German S3 guideline prostate cancer: aspects for the radiation oncologist.德国 S3 指南前列腺癌：放射肿瘤学家的观点。
Strahlenther Onkol. 2010 Oct;186(10):531-4. doi: 10.1007/s00066-010-2193-3. Epub 2010 Sep 30.
2
A systematic overview of radiation therapy effects in prostate cancer.前列腺癌放射治疗效果的系统综述。
Acta Oncol. 2004;43(4):316-81. doi: 10.1080/02841860410030661.
3
Normal tissue dosimetric comparison between HDR prostate implant boost and conformal external beam radiotherapy boost: potential for dose escalation.高剂量率前列腺植入后装放疗增敏与适形外照射放疗增敏之间的正常组织剂量学比较：剂量递增的潜力
Int J Radiat Oncol Biol Phys. 2000 Mar 1;46(4):851-8. doi: 10.1016/s0360-3016(99)00501-5.
4
Brachytherapy in the Management of Prostate Cancer.近距离放射治疗在前列腺癌治疗中的应用
Surg Oncol Clin N Am. 2017 Jul;26(3):491-513. doi: 10.1016/j.soc.2017.01.008. Epub 2017 May 11.
5
Challenge of dose escalation in locally advanced unfavourable prostate cancer using HDR brachytherapy.使用高剂量率近距离放射疗法对局部晚期高危前列腺癌进行剂量递增的挑战。
Prostate Cancer Prostatic Dis. 2006;9(4):370-3. doi: 10.1038/sj.pcan.4500893. Epub 2006 Jul 11.
6
Dose escalation using conformal high-dose-rate brachytherapy improves outcome in unfavorable prostate cancer.采用适形高剂量率近距离放射疗法进行剂量递增可改善预后不良的前列腺癌的治疗效果。
Int J Radiat Oncol Biol Phys. 2002 Jun 1;53(2):316-27. doi: 10.1016/s0360-3016(02)02733-5.
7
Phase II prospective study of the use of conformal high-dose-rate brachytherapy as monotherapy for the treatment of favorable stage prostate cancer: a feasibility report.适形高剂量率近距离放疗作为局限性前列腺癌单一疗法的II期前瞻性研究：可行性报告
Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):61-9. doi: 10.1016/s0360-3016(00)01463-2.
8
Survival Outcomes of Dose-Escalated External Beam Radiotherapy versus Combined Brachytherapy for Intermediate and High Risk Prostate Cancer Using the National Cancer Data Base.基于国家癌症数据库评估中高危前列腺癌调强放疗与近距离放疗联合应用的生存预后
J Urol. 2016 May;195(5):1453-1458. doi: 10.1016/j.juro.2015.11.005. Epub 2015 Nov 11.
9
Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study.前列腺癌放射治疗会增加后续患膀胱癌和直肠癌的风险：一项基于人群的队列研究。
J Urol. 2008 Nov;180(5):2005-9; discussion 2009-10. doi: 10.1016/j.juro.2008.07.038. Epub 2008 Sep 17.
10
Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.前瞻性剂量递增 II 期试验的长期结果：间质脉冲剂量率近距离放疗作为中高危前列腺癌的增敏剂。
Radiother Oncol. 2012 Aug;104(2):181-6. doi: 10.1016/j.radonc.2012.07.003. Epub 2012 Jul 30.

引用本文的文献

1
Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice.瑞士局限性和局部晚期前列腺癌的原发性放射治疗的共识与差异：实践模式调查
Strahlenther Onkol. 2015 Oct;191(10):778-86. doi: 10.1007/s00066-015-0849-8. Epub 2015 May 19.
2
Application of a hydrogel spacer for postoperative salvage radiotherapy of prostate cancer.水凝胶间隔物在前列腺癌术后挽救性放疗中的应用。
Strahlenther Onkol. 2015 Apr;191(4):375-9. doi: 10.1007/s00066-014-0769-z. Epub 2014 Oct 23.
3
Salvage radiotherapy in patients with prostate cancer and biochemical relapse after radical prostatectomy : Long-term follow-up of a single-center survey.

本文引用的文献

1
[Radiation therapy for prostate cancer in the new S3 guideline. Part 2: postoperative radiation therapy and brachytherapy].[新S3指南中前列腺癌的放射治疗。第2部分：术后放射治疗和近距离放射治疗]
Urologe A. 2010 Feb;49(2):216-20. doi: 10.1007/s00120-010-2242-7.
2
[Radiation therapy for prostate cancer in the new S3 guideline. Part 1: localized and locally advanced prostate cancer].[新版S3指南中前列腺癌的放射治疗。第1部分：局限性和局部晚期前列腺癌]
Urologe A. 2010 Feb;49(2):211-5. doi: 10.1007/s00120-010-2241-8.
3
Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09.
根治性前列腺切除术后生化复发的前列腺癌患者的挽救性放疗：单中心调查的长期随访。
Strahlenther Onkol. 2014 Aug;190(8):727-31. doi: 10.1007/s00066-014-0612-6. Epub 2014 Feb 28.
4
[The importance of pathology in the German prostate cancer study PREFERE].[病理学在德国前列腺癌研究PREFERE中的重要性]
Pathologe. 2013 Sep;34(5):449-62. doi: 10.1007/s00292-013-1788-8.
5
Re-implantation after insufficient primary 125-i permanent prostate brachytherapy.初次 125-i 前列腺近距离放射治疗不足后的再植入。
Radiat Oncol. 2013 Aug 6;8:194. doi: 10.1186/1748-717X-8-194.
6
Salvage radiotherapy in patients with persistently detectable PSA or PSA rising from an undetectable range after radical prostatectomy gives comparable results.根治性前列腺切除术后 PSA 持续可检测或 PSA 从不可检测范围升高的患者进行挽救性放疗可获得相当的结果。
World J Urol. 2013 Apr;31(2):423-8. doi: 10.1007/s00345-012-0860-y. Epub 2012 Mar 30.
7
Reduction of dosimetric impact of intrafractional prostate motion during helical tomotherapy.螺旋断层放疗中前列腺内运动的分次内剂量学影响降低。
Strahlenther Onkol. 2012 May;188(5):404-9. doi: 10.1007/s00066-011-0048-1. Epub 2012 Feb 16.
8
Radiotherapy for prevention and therapy of gynecomastia due to antiandrogen treatment in prostate cancer patients: a patterns-of-care study.放射治疗预防和治疗前列腺癌患者抗雄激素治疗引起的男性乳房发育症：一项治疗模式研究。
Strahlenther Onkol. 2011 Dec;187(12):771-7. doi: 10.1007/s00066-011-2283-x. Epub 2011 Nov 29.
9
A 6-month depot formulation of leuprolide acetate is safe and effective in daily clinical practice: a non-interventional prospective study in 1273 patients.醋酸亮丙瑞林 6 个月长效制剂在日常临床实践中是安全有效的：1273 例患者的非干预性前瞻性研究。
BMC Urol. 2011 Jul 29;11:15. doi: 10.1186/1471-2490-11-15.
10
Dose escalation for patients with decreasing PSA during radiotherapy for elevated PSA after radical prostatectomy improves biochemical progression-free survival: results of a retrospective study.根治性前列腺切除术后 PSA 升高的患者在放疗期间 PSA 下降时进行剂量升级可改善生化无进展生存期：一项回顾性研究的结果。
Strahlenther Onkol. 2011 Aug;187(8):467-72. doi: 10.1007/s00066-011-2229-3. Epub 2011 Jul 22.
随机对照试验比较常规剂量与高剂量适形放疗在早期前列腺腺癌：来自质子放射肿瘤学组/美国放射学院 95-09 的长期结果。
J Clin Oncol. 2010 Mar 1;28(7):1106-11. doi: 10.1200/JCO.2009.25.8475. Epub 2010 Feb 1.
4
A dosimetric selectivity intercomparison of HDR brachytherapy, IMRT and helical tomotherapy in prostate cancer radiotherapy.高剂量率近距离放射治疗、调强放射治疗和螺旋断层放射治疗在前列腺癌放射治疗中的剂量学选择性对比研究。
Strahlenther Onkol. 2009 Nov;185(11):736-42. doi: 10.1007/s00066-009-2009-5. Epub 2009 Nov 10.
5
Impact of the target volume (prostate alone vs. prostate with seminal vesicles) and fraction dose (1.8 Gy vs. 2.0 Gy) on quality of life changes after external-beam radiotherapy for prostate cancer.靶区体积（仅前列腺 vs. 包含精囊的前列腺）和分次剂量（1.8 Gy vs. 2.0 Gy）对前列腺癌外照射放疗后生活质量变化的影响。
Strahlenther Onkol. 2009 Nov;185(11):724-30. doi: 10.1007/s00066-009-2008-6. Epub 2009 Nov 10.
6
Duration of androgen suppression in the treatment of prostate cancer.雄激素抑制在前列腺癌治疗中的持续时间。
N Engl J Med. 2009 Jun 11;360(24):2516-27. doi: 10.1056/NEJMoa0810095.
7
Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.前列腺癌根治术后 III 期辅助放疗与单纯前列腺癌根治术治疗术后前列腺特异性抗原检测不到的 pT3 前列腺癌的比较：ARO 96-02/AUO AP 09/95
J Clin Oncol. 2009 Jun 20;27(18):2924-30. doi: 10.1200/JCO.2008.18.9563. Epub 2009 May 11.
8
Phantom measurements to quantify the accuracy of a commercially available cone-beam CT gray-value matching algorithm using multiple Fiducials.使用多个基准标记进行体模测量，以量化市售锥形束CT灰度值匹配算法的准确性。
Strahlenther Onkol. 2009 Jan;185(1):49-55. doi: 10.1007/s00066-009-1887-x. Epub 2009 Feb 18.
9
Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial.病理T3N0M0前列腺癌的辅助放疗可显著降低转移风险并提高生存率：一项随机临床试验的长期随访
J Urol. 2009 Mar;181(3):956-62. doi: 10.1016/j.juro.2008.11.032. Epub 2009 Jan 23.
10
Long-term health-related quality-of-life outcomes after permanent prostate brachytherapy.永久性前列腺近距离放射治疗后的长期健康相关生活质量结局
Onkologie. 2008 Nov;31(11):599-603. doi: 10.1159/000162270. Epub 2008 Oct 27.